Pharmac is refusing to bow to pressure and be rushed into funding a new treatment for advanced melanoma. Health Correspondent Karen Brown reports.
Pharmac is refusing to bow to pressure and be rushed into funding a new treatment for advanced melanoma. Health Correspondent Karen Brown reports.